EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally



RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally



Frontiers in Genetics 2: 100-100



Mutation in RAS proteins is one of the most common genetic alterations observed in human and experimentally induced rodent cancers. In vivo, oncogenic mutations have been shown to occur at exons 12, 13, and 61, resulting in any 1 of 19 possible point mutations in a given tumor for a specific RAS isoform. While some studies have suggested a possible role of different mutant alleles in determining tumor severity and phenotype, no general consensus has emerged on the oncogenicity of different mutant alleles in tumor formation and progression. Part of this may be due to a lack of a single, signature pathway that shows significant alterations between different mutations. Rather, it is likely that subtle differences in the activation, or lack thereof, of downstream effectors by different RAS mutant alleles may determine the eventual outcome in terms of tumor phenotype. This paper reviews our current understanding of the potential role of different RAS mutations on tumorigenesis, highlights studies in model cell culture and in vivo systems, and discusses the potential of expression array and computational network modeling to dissect out differences in activated RAS genes in conferring a transforming phenotype.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333367

Download citation: RISBibTeXText

PMID: 22303394

DOI: 10.3389/fgene.2011.00100



Related references

Effects of Rous virus (Briand strain) on mutations in Drosophila and relation between oncogenesis and mutations. Doklady Akademii Nauk SSSR 183(5): 1197-1200, 1968

The effect of Rouse virus (Briand strain) on the mutations in Drosophila and the relation between oncogenesis and mutations. Doklady Akademii Nauk SSSR: 183: 1197-1200, 1968

TP53 mutations and lung cancer: not all mutations are created equal. Clinical Cancer Research 20(17): 4419-4421, 2015

Not All SCID Pigs Are Created Equally: Two Independent Mutations in the Artemis Gene Cause SCID in Pigs. Journal of Immunology 195(7): 3171-3179, 2016

Preliminary studies on the evaluation, from the standpoint of breeding, of mutations induced by X-rays. II. Mutations of the chlorophyll system as test mutations for the action of irradiation in eliciting mutations in barley. Z. Pflanzenz, 25: 255-83, 1943

Genetic analysis of DNA replication in bacteria: dnaB mutations that suppress dnaC mutations and dnaQ mutations that suppress dnaE mutations in Salmonella typhimurium. Genetics 108(1): 25-38, 1984

Oncogenesis: only somatic mutations?. Epidemiologia E Prevenzione 39(3): 158-159, 2015

Insertional mutations during viral oncogenesis. Journal of Cellular Biochemistry Supplement (8 PART A): 34, 1984

R-2-hydroxyglutarate as the key effector of IDH mutations promoting oncogenesis. Cancer Cell 23(3): 274-276, 2013

Oncogenesis by mutations in anti-oncogenes: a view. Anticancer Research 10(2b): 475-487, 1990

Recessive mutations in the oncogenesis of certain solid tumors. Immunology Series 51: 145-167, 1990

Experimentally induced mutations in soyabean and their breeding value. II. Frequency of morphological mutations and their relation to chlorophyll mutations. Genetika, USSR 16(7): 1253-1259, 1980

Experimentally induced mutations in soybeans and their breeding value. II. Frequency of morphological mutations and their relation to chlorophyll mutations. Soviet genetics (pub 1981) 16(7): 807-813, 1981

Experimentally induced mutations in soybeans and their breeding value 2 frequency of morphological mutations and their relation to chlorophyll mutations. 1980

Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 95(2): 779-788, 2010